Free Trial
LON:VSN

Verseon (VSN) Share Price, News & Analysis

About Verseon Stock (LON:VSN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
74
74
52-Week Range
N/A
Volume
3,000 shs
Average Volume
75,334 shs
Market Capitalization
£112.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. The company is involved in developing oral anticoagulants for various cardiovascular indications with novel pharmacology; kallikrein inhibitors for the treatment of diabetic macular edema and hereditary angioedema; and novel angiogenesis inhibitors for the treatment of solid tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.

Receive VSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verseon and its competitors with MarketBeat's FREE daily newsletter.

VSN Stock News Headlines

Dragon Age: The Veilguard Review
Washington Is Broke—and Eyeing Your Savings Next
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
See More Headlines

VSN Stock Analysis - Frequently Asked Questions

Shares of VSN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Verseon investors own include Unity Biotechnology (UBX), Constellation Brands (STZ), NVIDIA (NVDA) and Netflix (NFLX).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:VSN
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
6.61
Book Value
GBX 21 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£112.24 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (LON:VSN) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners